Earnings Summary

Pds Biotechnology Corp’s net profit fell -202.81% since last year same period to $-19.14Mn in the Q4 2022. On a quarterly growth basis, Pds Biotechnology Corp has generated -157.77% fall in its net profits since last 3-months.

Pds Biotechnology Corp’s earning per share (EPS) estimates for the current quarter stand at -0.28 - a 0% jump from last quarter’s estimates.

Pds Biotechnology Corp’s earning per share (EPS) estimates for the current year stand at -0.28.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Pds Biotechnology Corp’s return on assets (ROA) stands at -0.5.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Pds Biotechnology Corp’s return on equity (ROE) stands at -1.14.